These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 17317514)
21. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure. Apple FS; Wu AH; Jaffe AS; Panteghini M; Christenson RH; ; Clin Biochem; 2008 Mar; 41(4-5):222-6. PubMed ID: 18035345 [No Abstract] [Full Text] [Related]
22. Improving risk stratification for heart failure. A role for serial testing of B-type natriuretic peptides? Daly MG; Frampton CM; Troughton RW J Am Coll Cardiol; 2010 Feb; 55(5):451-3. PubMed ID: 20117458 [No Abstract] [Full Text] [Related]
26. B-type natriuretic peptide-a CPK for heart-failure and beyond (ischemia)? Arora V; Bhandari S Indian Heart J; 2006; 58(2):90-2. PubMed ID: 18989049 [No Abstract] [Full Text] [Related]
27. [NT-proBNP in practice: from chemistry to medicine]. Jourdain P; Lefèvre G; Oddoze C; Sapin V; Dievart F; Jondeau G; Meune C; Galinier M Ann Cardiol Angeiol (Paris); 2009 Jun; 58(3):165-79. PubMed ID: 19457468 [TBL] [Abstract][Full Text] [Related]
28. The coming of age of natriuretic peptides: the emperor does have clothes! Maisel A J Am Coll Cardiol; 2006 Jan; 47(1):61-4. PubMed ID: 16386665 [No Abstract] [Full Text] [Related]
29. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure. Januzzi JL; Bayes-Genis A Drug News Perspect; 2009 Jun; 22(5):267-73. PubMed ID: 19609464 [TBL] [Abstract][Full Text] [Related]
30. Assessing prognosis in heart failure: you can see a lot if you look, but more if you look again. Squire I Eur Heart J; 2008 Apr; 29(8):959-60. PubMed ID: 18349028 [No Abstract] [Full Text] [Related]
31. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure. Apple FS; Wu AH; Jaffe AS; Panteghini M; Christenson RH; Cannon CP; Francis G; Jesse RL; Morrow DA; Newby LK; Storrow AB; Tang WH; Pagani F; Tate J; Ordonez-Llanos J; Mair J; ; Circulation; 2007 Jul; 116(5):e95-8. PubMed ID: 17630411 [No Abstract] [Full Text] [Related]
35. [Tailored drug therapy in heart failure--a future vision. Biological markers can support individually directed treatment]. Dahlström U Lakartidningen; 2009 Oct 14-20; 106(42):2674-5. PubMed ID: 19967945 [No Abstract] [Full Text] [Related]
36. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure. Omland T Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473 [TBL] [Abstract][Full Text] [Related]